Cargando…
Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations
Traditional genetic testing for patients with gastrointestinal stromal tumors (GISTs) focus on those with syndromic features. To assess whether expanded genetic testing of GIST patients could identify hereditary cancer predisposition, we analyzed matched tumor-germline sequencing results from 103 pa...
Autores principales: | Mandelker, Diana, Marra, Antonio, Mehta, Nikita, Selenica, Pier, Yelskaya, Zarina, Yang, Ciyu, Somar, Joshua, Mehine, Miika, Misyura, Maksym, Basturk, Olca, Latham, Alicia, Carlo, Maria, Walsh, Michael, Stadler, Zsofia K., Offit, Kenneth, Bandlamudi, Chaitanya, Hameed, Meera, Chi, Ping, Reis-Filho, Jorge S., Ceyhan-Birsoy, Ozge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807588/ https://www.ncbi.nlm.nih.gov/pubmed/36593350 http://dx.doi.org/10.1038/s41698-022-00342-z |
Ejemplares similares
-
A Clinical Approach to Detecting Germline Pathogenic Variants From Tumor-Only Sequencing
por: Ceyhan-Birsoy, PhD, Ozge, et al.
Publicado: (2020) -
Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients
por: Ceyhan-Birsoy, Ozge, et al.
Publicado: (2022) -
ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications
por: El Jabbour, Tony, et al.
Publicado: (2022) -
Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of “Second Hit” in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma
por: Zheng-Lin, Binbin, et al.
Publicado: (2022) -
Pathogenic Loss-of-Function Germline TERT Mutations in Patients With Solid Tumors
por: Walsh, Michael F., et al.
Publicado: (2019)